Equities

Kiniksa Pharmaceuticals International PLC

KNSA:NSQ

Kiniksa Pharmaceuticals International PLC

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)21.28
  • Today's Change0.19 / 0.90%
  • Shares traded81.07k
  • 1 Year change+34.77%
  • Beta0.2625
Data delayed at least 15 minutes, as of Nov 22 2024 18:42 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, cash reserves at Kiniksa Pharmaceuticals International PLC fell by 14.76m. However, the company earned 13.30m from its operations for a Cash Flow Margin of 4.92%. In addition the company generated 1.50m cash from financing while 29.56m was spent on investing.
Cash flow per share-0.0994
Price/Cash flow per share--
Book value per share6.06
Tangible book value per share5.83
More ▼

Balance sheet in USDView more

Kiniksa Pharmaceuticals International PLC has little financial risk as the capital structure does not rely on leverage.
Current ratio3.24
Quick ratio2.95
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.